TipRanks
Go Ultimate75% OFF

Ben Gil Price Insider Profile

4 Followers

Ben Gil Price, CEO and President at MetaVia, holds ― shares in MetaVia (Ticker: MTVA), holds 15.00K shares in Opus Genetics (Ticker: IRD), holds 37.33K shares in Sarepta Therapeutics (Ticker: SRPT).

Ben Gil Price's Trading History

IRD
Opus Genetics
Jan 31, 2019DirectorInformative Buy9.00K$62.70K
SRPT
Sarepta Therapeutics
Mar 16, 2016DirectorInformative Buy75.11K$665.22K
MTVA
MetaVia
―CEO and President――

You May Also Like

Ben Gil Price insider profile FAQ

What is the percentage of profitable transactions made by Ben Gil Price?
The percentage of profitable transactions made by Ben Gil Price is 50%.
What is the average return per transaction made by Ben Gil Price?
The average return per transaction made by Ben Gil Price is 17.50%.
What stocks does Ben Gil Price hold?
Ben Gil Price holds: MTVA, IRD, SRPT stocks.
What was Ben Gil Price's most profitable transaction?
Ben Gil Price’s most profitable transaction was an Informative Buy of SRPT stock on March 16, 2016. The return on the trade was 108.50%.
What is Ben Gil Price's role in MetaVia?
Ben Gil Price's role in MetaVia is CEO and President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.